David Silberman - 04 Jan 2024 Form 4 Insider Report for ORAMED PHARMACEUTICALS INC. (ORMP)

Role
Chief Financial Officer
Signature
/s/ David Silberman
Issuer symbol
ORMP
Transactions as of
04 Jan 2024
Net transactions value
$0
Form type
4
Filing time
08 Jan 2024, 16:39:04 UTC
Previous filing
31 May 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ORMP Common Stock Award +136,500 +59% 366,500 04 Jan 2024 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents Restricted Stock Units ("RSUs") that will vest in equal quarterly installments of 11,375 over a three year period starting January 8, 2024. The RSUs convert into the Issuer's Common Stock on a one-for-one basis.